Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients

Canadian Journal of Kidney Health and Disease
John PapastergiouBart van den Bemt

Abstract

Chronic kidney disease (CKD) is a condition presenting with long-term slow progression of structural and/or functional damage to the kidneys. Early detection is key to preventing complications and improving outcomes. Point-of-care estimated glomerular filtration rate (eGFR) screening technology allows for detection of abnormal kidney function in the community pharmacy setting. To evaluate the effectiveness of a community pharmacist-directed point-of-care screening program and to identify the prevalence of CKD in high-risk patients. Quantitative observational. Four community pharmacies in British Columbia over a 6-month period. In all, 642 participants with at least one CKD risk factor were identified and screened. Mean age was 60 years and females accounted for 55% of the study population. Serum creatinine was measured from peripheral blood using the HeathTab® screening system (Piccolo® Renal Function Panel with the Piccolo® blood chemistry analyzer). eGFR was calculated according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Patients provided a sample of peripheral blood via a self-administered finger-prick and analytical data to assess kidney function was reported including blood urea nitrogen (B...Continue Reading

References

Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
May 20, 2008·Primary Care·Robert ThomasJohn R Sedor
Apr 13, 2010·Lancet·Matthew T JamesMarcello Tonelli
Dec 20, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul E DrawzThomas H Hostetter
Mar 20, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·John PapastergiouPeter Tolios
May 8, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Paul AroraAlaa Badawi
Jul 3, 2013·Journal of Clinical Pharmacy and Therapeutics·A F J GeertsW W van Solinge
Feb 18, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul KomendaNavdeep Tangri
Dec 17, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ayub AkbariE Sohani Welcher
Aug 12, 2015·JAMA : the Journal of the American Medical Association·Milda R SaundersMonica Vela
Apr 15, 2016·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·John PapastergiouLeslie Young
May 21, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Lauren E GalbraithBrenda R Hemmelgarn
Apr 26, 2017·Nephron·Pierre DelanayeHans Pottel
May 12, 2017·Canadian Journal of Kidney Health and Disease·Braden MannsUNKNOWN Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD) Network

❮ Previous
Next ❯

Citations

Jan 13, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Kofi B MensahFrasia Oosthuizen
Jun 29, 2021·SSM - Population Health·Nicholas C CoombsSophia R Newcomer

❮ Previous
Next ❯

Software Mentioned

HealthTab
SeeKD
HealthTab ©

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.